Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

12.58
BATS BZX Real-Time Price
As of 9:53am ET
 -0.01 / -0.08%
Today’s Change
10.52
Today|||52-Week Range
19.98
-25.34%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close12.59
Today’s open12.62
Day’s range12.56 - 12.62
Volume1,000
Average volume (3 months)1,618,124
Market cap$1.9B
Dividend yield--
Data as of 9:53am ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-80.60%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book264.94

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...-0.55-0.93%
JUNOJuno Therapeutics In...-1.13-5.53%
RDUSRadius Health Inc+0.31+0.59%
AVXSAveXis Inc-0.40-0.75%
Data as of 9:56am ET, 12/06/2016

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts


Search for Jobs